55 Biggest Movers From Friday

Gainers

• CounterPath, Corp. CPAH shares jumped 304.1% to close at $3.92 on Friday after the company partnered with Honeywell to create unified communications solution for mobile devices and handheld scanners.
• Origin Agritech Limited SEED gained 46.9% to close at $10.24.
• Sorrento Therapeutics Inc SRNE rose 39.6% to close at $4.76 following news it received an unsolicited acquisition offer from private equity at $7 per share.
• Nektar Therapeutics NKTR gained 24.7% to close at $26.92 after the company and Bristol-Myers agreed to a new joint development plan to advance bempeg plus nivolumab into multiple new registrational trials.
• Monopar Therapeutics Inc. MNPR rose 23.6% to close at $22.00.
• Ultragenyx Pharmaceutical Inc. RARE shares gained 23.4% to close at $53.96 after the company announced positive topline cohort 3 results and improved longer-term Cohort 2 results from the Phase 1/2 study of DTX301 gene therapy.
• China Green Agriculture, Inc. CGA rose 23% to close at $3.85.
• PhaseBio Pharmaceuticals, Inc. PHAS shares rose 20.2% to close at $6.79 after the company announced a financing and co-development collaboration with SFJ Pharmaceuticals for PB2452. PhaseBio to receive $120 million in development funding.
• Venus Concept Inc. VERO rose 20% to close at $6.66.
• Caladrius Biosciences, Inc. CLBS climbed 18.8% to close at $3.48.
• Microbot Medical Inc. MBOT surged 18.7% to close at $13.17.
• Revance Therapeutics, Inc. RVNC gained 18.3% to close at $19.50 after the company signed US distribution agreement with TEOXANE SA.
• Aclaris Therapeutics, Inc. ACRS shares rose 17.2% to close at $2.18 after the company announced positive results from ATI-450-PKPD-101.
• OneConnect Financial Technology Co., Ltd. OCFT climbed 16.8% to close at $15.82.
• ASLAN Pharmaceuticals Limited ASLN gained 16.3% to close at $2.36.
• BioXcel Therapeutics, Inc. BTAI climbed 16.2% to close at $14.24.
• BeyondSpring Inc. BYSI gained 14.7% to close at $18.47.
• La Jolla Pharmaceutical Company LJPC rose 14.3% to close at $6.00.
• Nautilus, Inc. NLS gained 14.2% to close at $3.22.
• Atomera Incorporated ATOM surged 13.9% to close at $4.17.
• Edesa Biotech, Inc. EDSA gained 13.4% to close at $3.6062.
• SYNNEX Corporation SNX rose 13% to close at $145.56 after the company reported upbeat results for its fourth quarter and announced plans to separate into two publicly traded companies. The company also issued Q1 earnings guidance above analyst estimates.
• Kala Pharmaceuticals, Inc. KALA surged 12.8% to close at $5.32.
• CNS Pharmaceuticals, Inc. CNSP rose 12.4% to close at $4.99.
• DRDGOLD Limited DRD surged 10.6% to close at $6.06.
• Calithera Biosciences, Inc. CALA rose 10.6% to close at $6.49.
• Zynerba Pharmaceuticals, Inc. ZYNE climbed 10.5% to close at $5.62.
• PolarityTE, Inc. PTE gained 10% to close at $3.31.
• TRACON Pharmaceuticals, Inc. TCON gained 9% to close at $2.90.
• Soleno Therapeutics, Inc. SLNO rose 7% to close at $3.05.
• Beyond Meat, Inc. BYND rose 6.5% to close at $96.07 after climbing 10.76% on Thursday.
• Foamix Pharmaceuticals Ltd. FOMX rose 6.4% to close at $3.99.
• Simulations Plus, Inc. SLP rose 5.3% to close at $33.37 following strong Q1 results.

Check out these big penny stock gainers and losers

Losers

• Portola Pharmaceuticals, Inc. PTLA shares tumbled 40.3% to close at $14.76 on Friday after the company reported preliminary FY19 Andexxa global net revenues of $111 million.
• RumbleON Inc RMBL fell 26% to close at $0.60 after the company issued Q4 and FY19 sales guidance below analyst estimates, and reported a common stock offering of no disclosed size.
• Inpixon INPX fell 21.4% to close at $4.05 after falling 6.02% on Thursday.
• Six Flags Entertainment Corporation SIX fell 17.8% to close at $35.96 after the company disclosed that development of co-branded parks in China has encountered continued challenges. Wells Fargo downgraded the stock from Overweight to Equal-Weight and lowered the price target from $49 to $42 per share.
• Sportsman's Warehouse Holdings Inc SPWH fell 16.9% to close at $6.63 after the company lowered its guidance for FY19. The company also issued weak forecast for the fourth quarter.
• Applied Genetic Technologies Corporation AGTC fell 15.4% to close at $7.84 after rising 122.84% on Thursday.
• Kezar Life Sciences, Inc. KZR fell 13.9% to close at $3.29.
• Genetic Technologies Limited GENE dipped 13.1% to close at $4.11.
• Turning Point Therapeutics, Inc. TPTX dipped 13.1% to close at $56.82. Turning Point Therapeutics said Jean Cui will step down as chief scientific officer Jan. 31, with family reasons cited for the departure. Cui, however, will serve as a consultant and support the company during a transition period until June 30.
• EyeGate Pharmaceuticals, Inc. EYEG dropped 11.8% to close at $7.51.
• Aehr Test Systems AEHR fell 10.8% to close at $1.91 after the company reported Q2 results.
• Aptinyx Inc APTX fell 10.7% to close at $3.2150. Aptinyx priced its 10.17 million share common stock offering at $3 per share.
• Flexion Therapeutics, Inc. FLXN dropped 10.5% to close at $18.92.
• Check-Cap Ltd. CHEK tumbled 10.3% to close at $2.01.
• United Natural Foods, Inc. UNFI shares fell 10.3% to close at $8.48.
• Stage Stores, Inc. SSI dropped 10% to close at $7.32.
• Monaker Group, Inc. MKGI dipped 9.9% to close at $1.83.
• Atreca, Inc. BCEL dropped 9.7% to close at $14.61.
• Kimbell Royalty Partners, LP KRP fell 9.3% to close at $15.75 after the company reported a 5 million common unit offering. Kimbell Royalty Partners also reported a $175 Million acquisition of mineral and royalty interests in a cash and unit transaction.
• Pier 1 Imports, Inc. PIR dropped 6.9% to close at $3.50.
• Chembio Diagnostics, Inc. CEMI dropped 6.6% to close at $4.54 after the company reported the resignation of President and CEO John Sperzel.
• Grubhub Inc. GRUB fell 6% to close at $52.38. Grubhub said It 'unequivocally' isn't running a sale process, Bloomberg reported.